Maria Roberta Cilio, MD, PhD, Université Catholique de Louvain, Brussels, Belgium, discusses a novel approach to the detection and diagnosis of seizures and status epilepticus (SE) in neonates. She emphasizes the need to stratify patients’ treatment according to seizure semiology and etiology, and how this can inform precision medicine approaches. Precision medicine is already routinely used to treat SE in older children and adults. Prof. Cilio explains that early diagnosis using genomic sequencing and neuroimaging is critical to identify, differentiate, and treat SE in an etiology-specific manner. She asserts that this can be beneficial to avoid unnecessary treatments. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.